Together, these hormones may help create conditions that favor fat loss while preserving lean tissue. The extract group also showed a larger drop in visceral fat, with about 3.5 times the reduction in estimated visceral fat area seen in placebo [4]
Due to the legal landscape of peptides and research products, providing information that may imply anything beyond laboratory research use is a legal liability
Daily oral orforglipron (Foundayo): Weekly injectable semaglutide for weight loss (Wegovy) : Average weight loss of 14.9 percent of body weight after about 15 months, compared with 2.4 percent in a placebo group Average weight loss of 21 percent of body weight after about 16 months, compared with 3.1 percent in a placebo group Weekly injectable tirzepatide for weight loss (Zepbound): Secondary Health Benefits Though this entire family of drugs has benefits for metabolic health, not every particular drug has been approved for the same conditions
SSRP Institute News (2026) 11
References References Agnew, R (Jan 2013) 'Benjamin Moore FRS (1867-1922)', Ulster Medical Journal , 82/1, 131-4